POSSIBLE INVOLVEMENT OF OATP2B1 IN GASTROINTESTINAL TOXICITY INDUCED BY SN-38, THE ACTIVE METABOLITE OF ANTICANCER IRINOTECAN

被引：0
|
作者：
Fujita, Daichi [1 ]
Saito, Yoshimasa [2 ]
Nakanishi, Takeo [1 ]
Tamai, Ikumi [1 ]
机构：
[1] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Pharmaceut Sci, Dept Membrane Transport & Biopharmaceut, Kanazawa, Ishikawa, Japan
[2] Natl Canc Ctr, Dept Pharm, Tokyo, Japan
来源：
DRUG METABOLISM REVIEWS | 2015年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P522
引用
收藏
页码：287 / 288
页数：2
相关论文
共 50 条
  • [31] OATP1A/1B Transporters Affect Irinotecan and SN-38 Pharmacokinetics and Carboxylesterase Expression in Knockout and Humanized Transgenic Mice
    Iusuf, Dilek
    Ludwig, Marion
    Elbatsh, Ahmed
    van Esch, Anita
    van de Steeg, Evita
    Wagenaar, Els
    van der Valk, Martin
    Lin, Fan
    van Tellingen, Olaf
    Schinkel, Alfred H.
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (02) : 492 - 503
  • [32] Effects of Oral Administration of S-1 on the Pharmacokinetics of SN-38, Irinotecan Active Metabolite, in Patients With Advanced Colorectal Cancer
    Yokoo, Koji
    Hamada, Akinobu
    Tazoe, Kensuke
    Sasaki, Yutaka
    Saito, Hideyuki
    THERAPEUTIC DRUG MONITORING, 2009, 31 (03) : 400 - 403
  • [33] P-glycoprotein-dependent pharmacokinetics of irinotecan and its active metabolite, SN-38 in rats: Effect of verapamil
    Garg, Tripta
    Jaggi, Manu
    Khar, Roop K.
    Talegaonkar, Sushama
    ADMET AND DMPK, 2015, 3 (01): : 68 - 76
  • [34] Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer Patients
    Karas, Spinel
    Etheridge, Amy S.
    Tsakalozou, Eleftheria
    Ramirez, Jacqueline
    Cecchin, Erika
    van Schaik, Ron H. N.
    Toffoli, Giuseppe
    Ratain, Mark J.
    Mathijssen, Ron H. J.
    Forrest, Alan
    Bies, Robert R.
    Innocenti, Federico
    AAPS JOURNAL, 2020, 22 (03):
  • [35] Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer Patients
    Spinel Karas
    Amy S. Etheridge
    Eleftheria Tsakalozou
    Jacqueline Ramírez
    Erika Cecchin
    Ron H.N. van Schaik
    Giuseppe Toffoli
    Mark J. Ratain
    Ron H.J. Mathijssen
    Alan Forrest
    Robert R. Bies
    Federico Innocenti
    The AAPS Journal, 22
  • [36] Increased Plasma Concentrations of Unbound SN-38, the Active Metabolite of Irinotecan, in Cancer Patients with Severe Renal Failure
    Fujita, Ken-ichi
    Masuo, Yusuke
    Okumura, Hidenori
    Watanabe, Yusuke
    Suzuki, Hiromichi
    Sunakawa, Yu
    Shimada, Ken
    Kawara, Kaori
    Akiyama, Yuko
    Kitamura, Masanori
    Kunishima, Munetaka
    Sasaki, Yasutsuna
    Kato, Yukio
    PHARMACEUTICAL RESEARCH, 2016, 33 (02) : 269 - 282
  • [37] Increased Plasma Concentrations of Unbound SN-38, the Active Metabolite of Irinotecan, in Cancer Patients with Severe Renal Failure
    Ken-ichi Fujita
    Yusuke Masuo
    Hidenori Okumura
    Yusuke Watanabe
    Hiromichi Suzuki
    Yu Sunakawa
    Ken Shimada
    Kaori Kawara
    Yuko Akiyama
    Masanori Kitamura
    Munetaka Kunishima
    Yasutsuna Sasaki
    Yukio Kato
    Pharmaceutical Research, 2016, 33 : 269 - 282
  • [38] High-performance liquid chromatographic analysis of the anticancer drug irinotecan (CPT-11) and its active metabolite SN-38 in human plasma
    Schoemaker, NE
    Rosing, H
    Jansen, S
    Schellens, JHM
    Beijnen, JH
    THERAPEUTIC DRUG MONITORING, 2003, 25 (01) : 120 - 124
  • [39] SN-38, an active metabolite of irinotecan, enhances anti-PD-1 treatment efficacy in head and neck squamous cell carcinoma
    Lee, Yi-Mei
    Chen, Yu-Hsin
    Ou, Da-Liang
    Hsu, Chia-Lang
    Liu, Jia-Hua
    Ko, Jenq-Yuh
    Hu, Mickey C-T
    Tan, Ching-Ting
    JOURNAL OF PATHOLOGY, 2023, 259 (04): : 428 - 440
  • [40] An Accurate Assay for Simultaneous Determination of Irinotecan and Its Active Metabolite SN-38 in Rat Plasma by LC with Fluorescence Detection
    Zhang, Ziqiang
    Yao, Jing
    Wu, Xiaotao
    Zou, Jianjun
    Zhu, Jiabi
    CHROMATOGRAPHIA, 2009, 70 (3-4) : 399 - 405
12345